GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 198 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $719,000 | +116.6% | 10,558 | +1.5% | 0.29% | +133.3% |
| Q2 2022 | $332,000 | -35.8% | 10,406 | -30.3% | 0.12% | -46.8% |
| Q1 2022 | $517,000 | +18.3% | 14,938 | 0.0% | 0.23% | +40.0% |
| Q4 2021 | $437,000 | +51.2% | 14,938 | +31.5% | 0.16% | +29.9% |
| Q3 2021 | $289,000 | -33.4% | 11,358 | -8.4% | 0.13% | -28.7% |
| Q2 2021 | $434,000 | -27.3% | 12,396 | -15.4% | 0.18% | -29.4% |
| Q1 2021 | $597,000 | -3.2% | 14,654 | +2.8% | 0.25% | -1.6% |
| Q4 2020 | $617,000 | +20.0% | 14,254 | +52.8% | 0.26% | -5.2% |
| Q3 2020 | $514,000 | -4.6% | 9,328 | +9.2% | 0.27% | +5.9% |
| Q2 2020 | $539,000 | +37.9% | 8,542 | +11.6% | 0.26% | +58.4% |
| Q1 2020 | $391,000 | -40.8% | 7,657 | -7.8% | 0.16% | +49.1% |
| Q4 2019 | $660,000 | +190.7% | 8,303 | +77.5% | 0.11% | +134.8% |
| Q3 2019 | $227,000 | -12.7% | 4,677 | -5.3% | 0.05% | -16.4% |
| Q2 2019 | $260,000 | -22.6% | 4,938 | -22.1% | 0.06% | -92.3% |
| Q1 2019 | $336,000 | +15.5% | 6,342 | -10.6% | 0.72% | +1330.0% |
| Q4 2018 | $291,000 | -23.8% | 7,094 | -29.4% | 0.05% | +28.2% |
| Q3 2018 | $382,000 | -51.0% | 10,053 | -41.7% | 0.04% | -94.3% |
| Q2 2018 | $780,000 | -16.5% | 17,249 | -10.8% | 0.69% | -14.8% |
| Q1 2018 | $934,000 | +152.4% | 19,331 | +105.9% | 0.81% | +74.6% |
| Q4 2017 | $370,000 | +0.5% | 9,390 | -20.7% | 0.46% | +828.0% |
| Q3 2017 | $368,000 | +25.2% | 11,845 | +10.1% | 0.05% | +13.6% |
| Q2 2017 | $294,000 | -54.1% | 10,761 | -38.1% | 0.04% | -61.4% |
| Q1 2017 | $641,000 | +182.4% | 17,385 | +10.6% | 0.11% | +67.6% |
| Q4 2016 | $227,000 | -15.9% | 15,719 | +34.2% | 0.07% | -48.1% |
| Q3 2016 | $270,000 | +39.2% | 11,710 | 0.0% | 0.13% | -9.0% |
| Q2 2016 | $194,000 | +61.7% | 11,710 | +54.4% | 0.14% | -12.7% |
| Q1 2016 | $120,000 | – | 7,582 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |